YOLFTbeta
Shandong Wohua Pharmaceutical Co Ltd

Shandong Wohua Pharmaceutical Co Ltd

002107 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

5.88CNY-0.12 (-2.00%)

Price History

Full chart

Market Stats

Previous Close6.00
Open6.01
Day Range5.87 – 6.02
52-Week Range5.37 – 8.32
Volume4.82M
Market Cap4.09B
P/E (TTM)33.76
Forward P/E120.48
EPS0.21
Dividend Yield3.70%
Beta0.33
50-Day Avg6.55
200-Day Avg6.76

About

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu tablets, Hedan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, including Gusukang capsules/granules and Yidu Hanbi liquid; Yidu cold-rheumatism medicinal wine ingredients; brain blood circulation oral solution; Amber stone granules for urinary system diseases; Children's antipyretic granules for pediatric medication; Anti-itching granules for skin diseases; and Bile grass capsule for digestive and gynecological diseases, as well as Silkworm Nourishing Blood and Benefiting Kidney Granules for gynecological medication. In addition, the company offers Amber Xiaoshi granules, and Siyu Yangxue Yishen granules; Yanreqing granules, Antiviral oral liquid, and Niuhuang Yijin tablets for the treatment of dry throat and sore throat; Yinhuang granules for the treatment of wind-heat colds; Tongxuan Lifei pills for the treatment of wind-cold colds; Fangfeng Tongsheng pills for colds on the surface and heat inside; Huoxiang Zhengqi Water for the treatment of summer-heat colds; Shenling Baizhu, Buzhong Yiqi, and Xiangsha Liujun pills for the treatment of physical weakness colds; and Juhong Li Gao for the treatment of dry coughs with little sputum. The company was founded in 2003 and is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. operates as a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Shengting Li
  • Employees1.02K
  • HeadquartersNo. 3517 Liyuan Street, Weifang, China, 261205, China
  • Websitehttps://www.wohua.cn

Leadership

  • Mr. Shengting LiPresident · b. 1968
  • Mr. Jiong WangCFO, Accounting Supervisor & Director · b. 1973
  • Mr. Ge ZhangDirector & Secretary of The Board · b. 1970
  • Ms. Yingzi ZengVice President · b. 1963
  • Ms. Qian YangDeputy General Manager · b. 1968

Financials

Income Statement

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue74.73M91.42M111.33M122.68M129.45M196.54M172.20M90.92M149.03M209.61M255.60M437.86M468.92M562.85M726.65M774.42M860.29M1.01B942.67M1.01B909.51M763.79M816.95M
Growth (%)-+22.33%+21.78%+10.19%+5.52%+51.83%-12.39%-47.20%+63.91%+40.65%+21.94%+71.31%+7.09%+20.03%+29.10%+6.57%+11.09%+16.95%-6.30%+7.65%-10.38%-16.02%+6.96%
Cost of Revenue15.77M18.29M20.43M22.82M26.01M67.72M40.90M24.73M34.60M50.11M55.73M136.48M130.28M142.85M156.98M178.88M204.21M226.33M214.94M255.27M234.75M210.83M203.07M
Gross Profit58.96M73.13M90.90M99.86M103.44M128.82M131.29M66.19M114.43M159.50M199.87M301.38M338.64M420.00M569.66M595.53M656.08M779.75M727.74M759.55M674.76M552.97M613.89M
Gross Margin78.89%79.99%81.65%81.40%79.90%65.54%76.25%72.80%76.78%76.09%78.20%68.83%72.22%74.62%78.40%76.90%76.26%77.50%77.20%74.85%74.19%72.40%75.14%
Operating Expense43.49M45.07M56.00M62.31M62.73M66.54M83.83M166.04M109.97M157.20M190.84M258.46M260.43M353.12M477.86M551.35M544.65M557.15M535.05M647.23M618.27M508.38M510.29M
Operating Income15.47M28.06M34.89M37.54M40.70M62.28M47.46M-99.84M4.46M2.30M9.04M42.91M78.22M66.88M91.80M44.18M111.43M222.60M192.69M112.31M56.49M44.59M103.60M
Operating Margin20.70%30.69%31.34%30.61%31.44%31.69%27.56%-109.81%2.99%1.10%3.54%9.80%16.68%11.88%12.63%5.71%12.95%22.13%20.44%11.07%6.21%5.84%12.68%
EBITDA21.15M34.47M40.59M43.66M47.19M68.71M57.92M-89.38M14.32M26.88M31.50M74.78M116.02M99.56M121.29M69.00M133.03M254.60M228.97M145.91M87.29M74.66M133.06M
EBITDA Margin28.30%37.71%36.46%35.59%36.46%34.96%33.64%-98.31%9.61%12.82%12.33%17.08%24.74%17.69%16.69%8.91%15.46%25.31%24.29%14.38%9.60%9.77%16.29%
Net Income12.49M23.13M28.44M31.50M35.42M53.64M52.37M-97.81M7.43M8.34M10.62M43.35M71.37M48.81M57.03M45.65M95.80M178.88M163.39M107.39M58.77M36.40M95.72M
Net Income Margin16.71%25.30%25.54%25.68%27.36%27.29%30.41%-107.58%4.99%3.98%4.16%9.90%15.22%8.67%7.85%5.89%11.14%17.78%17.33%10.58%6.46%4.77%11.72%
R&D---------17.16M19.59M49.93M35.04M29.92M76.80M103.67M127.91M139.00M147.14M186.40M163.76M110.11M105.24M
R&D as % of Total Revenue---------8.19%7.67%11.40%7.47%5.32%10.57%13.39%14.87%13.82%15.61%18.37%18.01%14.42%12.88%
Interest Expense3.08M3.53M2.71M3.12M3.15M2.73M010.32M7.76M6.10M6.25M1.56M8.80M10.14M9.30M6.50M1.53M5.98M5.97M129.08K128.80K74.83K101.95K
Interest Expense % of Total Revenue4.12%3.87%2.43%2.55%2.43%1.39%0.00%11.35%5.21%2.91%2.45%0.36%1.88%1.80%1.28%0.84%0.18%0.59%0.63%0.01%0.01%0.01%0.01%

Balance Sheet

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets134.97M152.92M194.94M237.01M452.54M712.11M773.86M636.14M622.35M643.70M645.05M668.64M668.23M705.63M855.50M922.38M1.01B1.37B1.16B1.10B1.14B985.73M977.37M
Total Liabilities83.28M70.30M83.88M94.44M110.32M74.23M85.41M45.49M36.28M49.28M40.01M36.89M120.97M132.99M199.71M226.60M232.87M452.08M231.83M310.20M311.23M262.80M244.73M
Total Equity51.69M82.62M111.06M142.57M342.22M637.88M688.45M590.64M586.07M594.41M605.04M631.74M476.28M489.02M548.39M594.05M671.98M807.40M820.72M746.50M805.27M697.37M723.82M
Cash33.47M53.65M18.21M40.02M177.57M347.21M374.16M334.79M299.17M305.10M314.41M336.02M191.07M194.38M304.87M322.92M300.69M494.43M326.84M278.29M401.10M344.77M394.41M
Total Debt63.00M46.00M49.50M54.50M74.50M20.00M30.00M20.00M10.00M---30.13M30.13M27.78M1.38M1.95M188.84M2.83M1.41M2.73M1.15M2.86M
Net Debt29.53M-7.65M31.29M14.48M-103.07M-327.21M-344.16M-314.79M-289.17M-305.10M-314.41M-336.02M-160.94M-164.25M-277.09M-321.54M-298.74M-305.59M-324.02M-276.88M-401.10M-343.62M-391.55M

Cash Flow

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow18.17M33.77M13.01M46.05M10.46M35.59M-21.24M-15.28M1.36M33.86M15.15M26.58M132.82M72.91M123.88M107.88M31.66M196.58M200.12M185.26M129.25M91.51M128.53M
Investing Cash Flow-2.46M-462.06K-49.65M-26.23M-54.53M-52.58M27.13M-18.89M-32.28M-26.65M-14.24M-3.33M-9.33M-24.63M-15.04M-62.23M-35.17M24.73M-19.08M-5.60M-2.62M-3.60M14.61M
Financing Cash Flow11.74M-13.12M1.19M1.99M181.63M186.63M21.06M-5.20M-4.70M-1.28M8.40M-1.63M-285.29M-44.97M1.65M-27.78M-18.67M-32.95M-343.69M-229.32M-3.55M-144.65M-91.97M
Capital Expenditure2.59M698.06K9.75M66.32M54.52M52.58M11.12M18.89M36.84M26.65M14.25M3.43M9.60M27.66M15.07M63.10M32.23M54.17M19.08M6.77M2.72M3.82M864.51K
Free Cash Flow15.59M33.07M3.26M-20.27M-44.06M-16.99M-32.36M-34.17M-35.48M7.21M904.66K23.15M123.22M45.25M108.81M44.79M-573.32K142.41M181.04M178.49M126.53M87.69M127.66M
Dividends Paid2.97M9.33M2.71M3.01M20.05M22.04M-----9.84M34.44M35.45M18.67M18.67M18.67M47.79M154.86M150.07M-144.30M69.27M
FCF to OCF85.77%97.93%25.07%-44.01%-421.42%-47.74%152.36%223.63%-2605.33%21.28%5.97%87.11%92.78%62.07%87.83%41.52%-1.81%72.44%90.47%96.35%97.90%95.82%99.33%
Dividend Paid to FCF19.08%28.21%82.96%-14.84%-45.51%-129.72%-----42.50%27.95%78.33%17.16%41.68%-3255.87%33.56%85.54%84.08%-164.57%54.26%

Earnings

Report DateMar 31, 2009Aug 2, 2009Oct 23, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Oct 21, 2016Jan 24, 2017Apr 25, 2017Aug 29, 2017Oct 30, 2017Dec 31, 2017Apr 27, 2018Jul 19, 2018Oct 30, 2018Jan 31, 2019Apr 28, 2019Aug 29, 2019Oct 28, 2019Mar 28, 2020Apr 28, 2020Jul 15, 2020Oct 15, 2020Jan 20, 2021Apr 6, 2021Jul 29, 2021Oct 28, 2021Jan 20, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 22, 2023Apr 26, 2023Jul 28, 2023Oct 26, 2023Mar 29, 2024Apr 26, 2024Aug 2, 2024Oct 25, 2024Dec 31, 2024Apr 25, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate-0.040.05------------------------------------------------------------------
EPS Actual0.030.07-0.010.030.02-0.05-0.05-0.08-0.010.010.010.010.00-0.000.000.010.000.000.010.010.000.000.020.040.030.030.040.020.030.020.030.010.030.030.04-0.010.030.040.01-0.000.020.030.040.120.120.080.090.070.090.090.060.050.050.050.040.050.040.020.040.000.020.000.020.020.040.040.030.060.06
Surprise-75.00%-120.00%------------------------------------------------------------------
Timing-After-hoursPre-market---------------------------Pre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market---After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-After-hours----

Key Statistics & Ratios

Market Cap4.09B
Enterprise Value3.78B
Trailing P/E33.76
Forward P/E120.48
PEG Ratio0.00
Price / Sales5.21
Price / Book5.89
EPS0.21
Book Value1.23
Revenue (TTM)784.94M
Gross Profit (TTM)605.21M
EBITDA158.67M
Profit Margin15.11%
Operating Margin20.95%
Return on Equity16.21%
Return on Assets8.04%
Shares Outstanding577.21M
Shares Float277.64M
Beta0.33
Dividend Yield3.70%
Dividend Rate0.26
Payout Ratio1.73%

Dividends

20262×
0.12Aug 18, 20260.15Mar 5, 2026
20251×
0.12Sep 11, 2025
20241×
0.25May 24, 2024
20221×
0.26Mar 8, 2022
20211×
0.26Apr 9, 2021
20201×
0.07May 29, 2020
20191×
0.03Apr 16, 2019
20161×
0.06May 19, 2016
20151×
0.06Mar 19, 2015
20141×
0.02Aug 21, 2014
20081×
0.04May 21, 2008
20071×
0.04Jun 7, 2007

Stock Splits

  • May 29, 20201.6:1
  • Mar 19, 201522:10
  • Jul 10, 200920:10